Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

Targeted Delivery of Bortezomib Using Retinoid-Based Nanoparticle: Modulating Liver Fibrosis through the TGF-β1/Smad3 Pathway

Samaneh Siapoush , Mohammad Rahmati, Morteza Milani, Behzad Hatami, Nosratollah Zarghami, Abbas Ebrahimi-kalan, Mohammadreza Zali, Kaveh Baghaei*

Adv Pharm Bull. doi: 10.34172/apb.43295 | Published on: 2025 Feb 12

PDF

Research Article

Vemurafenib induces senescence and increased adhesive features in melanoma cells: putative role of cell plasticity in drug resistance

Alexandra Esimbekova , Vasiliy Belenyuk, Andrey Savchenko , Tatiana Ruksha*

Adv Pharm Bull. doi: 10.34172/apb.42808 | Published on: 2025 Feb 12

PDF

Editorial

c-Abl Inhibitors in Parkinson's: Exploring Hypotheses on Alpha-Synuclein Modulation

Jyutia Nargish , Hirok Jyoti Baishya , Piyong Sola*

Adv Pharm Bull. doi: 10.34172/apb.42806 | Published on: 2025 Feb 09

PDF

Research Article

PTEN and p53 combined gene therapy promote apoptosis and chemosensitivity to oxaliplatin in colorectal cancer: An in vitro study

Narjes Nakhaee , Sirous Zeinali* , Mahboubeh Kabiri* , Ladan Teimoori Toolabi

Adv Pharm Bull. doi: 10.34172/apb.43371 | Published on: 2025 Feb 09

PDF

Research Article

Safety and feasibility of blockade of NK group-2 member-A receptor in natural killer cells combined with cetuximab antibody in patients with advanced gastric adenocarcinoma

Maryam Samareh Salavatipour , Shirin Tavakoli, Maryam Barkhordar, Iman Seyhoun, Nasim Vousooghi, Mohammad Vaezi, Afshin Ghaderi, Tahereh Bakhtiari, Ardeshir Ghavamzadeh, Javad Verdi* , Mohammad Ahmadvand*

Adv Pharm Bull. doi: 10.34172/apb.43859 | Published on: 2025 Feb 09

PDF

Research Article